Delivery Order SPE2DB20D3103-SPE2DB22FM9A8
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 40 mg tablets. The contract has a firm-fixed price of $1,355.12 and an ultimate completion date of August 21, 2024. AmerisourceBergen has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan 40 mg tablets, with a ceiling value of $1,424.67 and a period of performance through March 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,014.63, is for the delivery of Telmisartan 40 mg tablets in 30-count packages. The order has a firm fixed-price pricing type and a completion date of July 10, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Telmisartan 40 mg tablets. The contract has a ceiling value of $2,545.03 and a period of performance running through February 6, 2024. The contract is a firm-fixed-price Delivery Order, with no set-aside designation, indicating full and open competition. Amerisourcebergen, as a major pharmaceutical distributor,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,851.20 firm fixed-price contract is for the delivery of Telmisartan 40 mg tablets to support military healthcare programs. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Telmisartan 40 mg tablets, a cardiovascular medication, with a ceiling value of $3,068.85. The contract was awarded on March 9, 2022, with a completion date of March 10, 2022, and was not set aside for any specific business type. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor, holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets. The $1,409.50 firm fixed price contract has an ultimate completion date of August 19, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities to various federal agencies. This contract is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 40 mg tablets. The contract has a total ceiling value of $40,017.75 and a completion date of October 21, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,336.61, is for the delivery of Telmisartan 40 mg tablets. It is a firm-fixed-price delivery order contract with a completion date of February 8, 2024. The contract is not designated under any set-aside program. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Telmisartan 40mg tablets, a pharmaceutical product. The contract has a potential value of $3,515.53 and a completion date of January 22, 2024. This delivery order is part of Amerisourcebergen's broader work supplying pharmaceuticals and medical supplies to DLA Troop...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM9A8Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 40 mg tablets. The contract, valued at $9,841.85, was awarded on March 4, 2022, with a completion date of March 7, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 3/4/22 |